How Long After Starting Wegovy Will You Lose Weight?

What the STEP 1 trial actually showed, week by week

The STEP 1 trial enrolled 1,961 adults with obesity or overweight plus a weight-related condition, and followed them for 68 weeks on semaglutide 2.4mg. Published in the New England Journal of Medicine, it remains the primary evidence base for Wegovy's timeline. The average weight reduction across the full treatment group was around 15% of starting body weight, roughly 15kg for someone beginning at 100kg.

What the headline figure doesn't show is the shape of that journey. Weight loss in the trial was not linear. The first four weeks produced a small but real reduction, largely because semaglutide slows gastric emptying and damps appetite signals fairly quickly. Progress then built through the dose-escalation phase, picking up pace as participants moved from 0.25mg through 0.5mg, 1.0mg and 1.7mg toward the 2.4mg maintenance dose. The steepest cumulative losses appeared between roughly weeks 20 and 44, after most participants had reached or approached their maintenance dose. Weight loss then continued, at a shallower gradient, through to week 68.

One honest note: the trial included structured lifestyle support. If you're wondering how long after starting Wegovy you'll see results, weight loss in everyday practice (without that formal structure) can look different for any individual. That doesn't diminish the medicine's effect, but it does mean setting realistic week-one expectations matters.

How the titration schedule shapes your first four months

Wegovy's dosing schedule is a clinical feature, not a bureaucratic hurdle. The starting dose of 0.25mg is there to help your body adjust, reducing the nausea and digestive discomfort that can hit harder when semaglutide is introduced too quickly. Most people move up approximately every four weeks, spending time at 0.5mg, then 1.0mg, then 1.7mg before reaching 2.4mg, a process that takes around 16 weeks in total.

This matters for timeline expectations. If you weigh yourself at week two and see only a small change, that's expected. Your prescriber hasn't started you on the wrong dose. The treatment is working as designed. What people often find is that appetite shifts noticeably even at lower doses (portion sizes feel easier to reduce, the pull toward snacking quietens) even before the scale reflects it.

For a fuller picture of what those early weeks feel like, the page on starting Wegovy and what to expect covers the practical side of that adjustment period. The full breakdown of how long Wegovy takes to work goes deeper into the pharmacology for those who want it.

A prescriber at nume reviews every patient's progress before each repeat order, never an algorithm. That review is the point at which titration pace or any concerns get addressed.

Why results vary between people, and when to flag slow progress

Fifteen percent is an average. In the STEP 1 trial, the range of individual outcomes was wide: some participants lost considerably more, some less. Factors that influence the pace include starting weight, metabolic history, whether other conditions are present, how well gastrointestinal side effects are managed during titration, and lifestyle alongside the medicine.

If you've ever waited months for an NHS referral only to be told the waiting list is another year, it's understandable to want fast answers here. The honest answer is that semaglutide isn't a quick fix, it's a medicine that works steadily, over months, with a clinical team behind it.

The NHS's semaglutide guidance notes that if a patient hasn't lost at least 5% of their body weight after six months at the maintenance dose, continuing should be reviewed with their prescriber. That's not a failure, it's a safety checkpoint built into responsible prescribing. NICE's recommendation for semaglutide (Wegovy) under TA875 includes that same criterion as part of the clinical decision-making framework.

For a side-by-side look at how Wegovy's typical pace compares with tirzepatide, the detailed look at Wegovy's weight loss rate covers the comparison evidence. And if cost is a factor in your thinking, the UK cost context for Wegovy explains what a legitimate private prescription typically includes.

Practical ways to support the timeline

The trial participants who achieved the largest losses were also engaging with lifestyle changes alongside the medicine. Semaglutide reduces appetite; what you do with that reduction still matters. Protein intake, regular movement and staying well hydrated all become easier to manage when hunger isn't driving every food decision, and they compound the medicine's effect over months.

Storage and consistency also influence the timeline in ways people underestimate. Wegovy must be kept refrigerated between 2°C and 8°C; the patient information leaflet gives the exact room-temperature window if you need to take it out of the fridge temporarily. A missed injection, or one delayed by several days, can slow progress and increase the likelihood of side effects when the next dose lands.

The broader Wegovy treatment guide covers everything from eligibility to side-effect management. If you're still working out whether Wegovy or another treatment is the right fit, the weight-loss treatments overview sets out the options clearly.

When you're ready to have a prescriber look at your specific situation, checking your eligibility for a free consultation is the straightforward next step.